Literature DB >> 8625929

Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice.

K F Malik1, W S Young.   

Abstract

Leptin (OB protein) fused to the FLAG epitope and a kinase recognition site was expressed in bacteria, immunopurified, and phosphorylated using [gamma-(33)P] ATP. The resulting probe was used to characterize the distribution of leptin binding sites within brain sections of normal, ob/ob, and db/db C57BL/6J male mice. Leptin binding sites were found in leptomeninges and choroid plexus. Leptin binding within the choroid plexus is slightly elevated in ob/ob mice when compared to normal males (p<0.05). Binding of leptin by the choroid plexus of db/db male mice is lower than in normal males (p<0.05), but normally distributed. Based on the association and dissociation rates of leptin binding on tissue sections, we estimate the K(D) of the choroid plexus site at 0.25X10(-9) M. From our results, we hypothesize that the binding of leptin to its site may cause the release or transport of uncharacterized factor(s) into the cerebral spinal fluid (CSF) to affect neuronal populations controlling feeding and metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625929     DOI: 10.1210/endo.137.4.8625929

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Immunohistochemical Expression of Leptin in Non Melanoma Skin Cancer.

Authors:  Azza G A Farag; Nada Farag Elnaidany; Marwa Mohammed Serag El-Dien
Journal:  J Clin Diagn Res       Date:  2016-08-01

2.  Leptin, leptin gene and leptin receptor gene polymorphism in heart failure with preserved ejection fraction.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Rasha H Mohamed; Heba F Pasha
Journal:  Heart Vessels       Date:  2011-05-17       Impact factor: 2.037

Review 3.  Leptin and leptin receptor in anterior pituitary function.

Authors:  R V Lloyd; L Jin; I Tsumanuma; S Vidal; K Kovacs; E Horvath; B W Scheithauer; M E Couce; B Burguera
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

Review 4.  Limits to sustained energy intake IX: a review of hypotheses.

Authors:  John R Speakman; Elzbieta Król
Journal:  J Comp Physiol B       Date:  2005-07-27       Impact factor: 2.200

5.  Potential prognostic value of leptin receptor in hepatocellular carcinoma.

Authors:  S-N Wang; S-C Chuang; Y-T Yeh; S-F Yang; C-Y Chai; W-T Chen; K-K Kuo; J-S Chen; K-T Lee
Journal:  J Clin Pathol       Date:  2006-03-24       Impact factor: 3.411

6.  Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels.

Authors:  P L Golden; T J Maccagnan; W M Pardridge
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

7.  Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma.

Authors:  Kaouther Snoussi; A Donny Strosberg; Noureddine Bouaouina; Slim Ben Ahmed; A Noureddine Helal; Lotfi Chouchane
Journal:  BMC Cancer       Date:  2006-02-20       Impact factor: 4.430

8.  The immunohistochemical peptidergic expression of leptin is associated with recurrence of malignancy in laryngeal squamous cell carcinoma.

Authors:  S Gallina; F Sireci; F Lorusso; D V DI Benedetto; R Speciale; D Marchese; C Costantino; G Napoli; V Tessitore; D Cucco; A Leone; G Bonaventura; M L Uzzo; G F Spatola
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-02       Impact factor: 2.124

Review 9.  Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.

Authors:  Ebtesam A Al-Suhaimi; Adeeb Shehzad
Journal:  Eur J Med Res       Date:  2013-05-01       Impact factor: 2.175

Review 10.  Hypothalamic control of brown adipose tissue thermogenesis.

Authors:  Sebastien M Labbé; Alexandre Caron; Damien Lanfray; Boris Monge-Rofarello; Timothy J Bartness; Denis Richard
Journal:  Front Syst Neurosci       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.